PLYMOUTH MEETING, PA — Research published in the April 2025 issue of JNCCN–Journal of the National Comprehensive Cancer ...

Cipla has secured USFDA approval to market a generic version of Abraxane, paclitaxel protein-bound particles for injectable ...

The use of ablative radiation therapy (A-RT) led to promising overall survival and effective local tumor control in patients ...